Xenetic Biosciences Revenue

Biotechnology Research • Framingham, Massachusetts, United States • 1-10 Employees

Xenetic Biosciences revenue & valuation

Annual revenue	$2,446,221
Revenue per employee	$350,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,900,000
Total funding	$488,800

Key Contacts at Xenetic Biosciences

Scott Maguire

Chief Executive Officer

Grigory Borisenko

Member Board Of Directors

Dmitry Genkin

Director

Company overview

Headquarters	40 Speen Street, Suite 102, Framingham, MA 01701, US
Phone number	+17817787720
Website	xeneticbio.com
NAICS	541714
SIC	873
Employees	1-10
Socials

About Xenetic Biosciences

Xenetic Biosciences, Inc. (NASDAQ: XBIO) is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen™, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen™ has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

C-Suite

Employees by Department

Xenetic Biosciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Xenetic Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-11-12	14	$488,800

Funding Insights

$488,800

Total funding amount

$488,800

Most recent funding amount

Number of funding rounds

Xenetic Biosciences Tech Stack

Discover the technologies and tools that power Xenetic Biosciences's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

HSTS

Security

FancyBox

JavaScript libraries

Open Graph

Miscellaneous

PWA

Miscellaneous

Bootstrap

UI frameworks

Google Analytics

Analytics

hCaptcha

Security

Google Font API

Font scripts

Microsoft 365

Frequently asked questions

Xenetic Biosciences is located in Framingham, Massachusetts, US.

You can reach Xenetic Biosciences at +17817787720.

Xenetic Biosciences generates an estimated annual revenue of $2,446,221. This revenue figure reflects the company's market position and business performance in its industry.

Xenetic Biosciences has an estimated valuation of $7,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Xenetic Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Xenetic Biosciences has raised a total of $488,800 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Xenetic Biosciences

Scott Maguire

Chief Executive Officer

Grigory Borisenko

Member Board Of Directors

Dmitry Genkin

Director

4.8

40,000 users